Vijaya Diagnostic Centre Ltd. (VIJAYA) AI Stock Analysis

• Market Cap: ₹100.16B
• Dividend Yield: 0.2%
• Average Volume (3M): 7.14K
• Price to Earnings (P/E): 63.1
• Beta (1Y): 0.49
• Revenue Growth: 16.71%
• EPS Growth: 13.92%
• Country: IN
• Employees: 2,053
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Diagnostics & Research
• EPS (TTM): 4.20
• Shares Outstanding: 102,724,940
• 10 Day Avg. Volume: 16,300
• 30 Day Avg. Volume: 7,139
• PEG Ratio: 3.49
• Price to Book (P/B): 12.57
• Price to Sales (P/S): 14.69
• P/FCF Ratio: 77.60
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 21.49
• Revenue Forecast (FY): ₹9.42B

• Rating: 75 Outperform
• Price Target: ₹1,012.00 ▼(-4.11% Downside)
• Action: Upgraded Date: 12/05/25
• Date: Action: Upgraded 12/05/25

Vijaya Diagnostic Centre Ltd. demonstrates strong financial performance with robust revenue growth and profitability, which significantly contributes to its overall score. Technical analysis indicates positive momentum, though caution is advised due to a high RSI. The valuation is a concern with a high P/E ratio, suggesting potential overvaluation. The absence of earnings call and corporate events data did not impact the score.

Positive Factors

Revenue Growth & Profitability

Sustained double‑digit revenue growth combined with very high gross and healthy net margins indicates durable demand, pricing power, and efficient cost structure. Over 2–6 months this supports reinvestment in network expansion, higher retention of profits, and resilience to volume swings.

Negative Factors

Fee-for-Service / Out-of-Pocket Reliance

Heavy dependence on fee‑for‑service and out‑of‑pocket payments exposes revenue to affordability constraints, shifts in patient behavior, and reimbursement policy changes. Structural pressure on pricing or slower consumer demand could compress volumes and revenues over the medium term.

Vijaya Diagnostic Centre Ltd. Business Overview & Revenue Model

Company Description

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. It offers laboratory services, including clinical biochemistry, haematology and immune-haematology, clinical pathology, histopathology and cytopathology, microbio...

Read more

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. It offers laboratory services, including clinical biochemistry, haematology and immune-haematology, clinical pathology, histopathology and cytopathology, microbio...

How the Company Makes Money

Vijaya Diagnostic Centre Ltd. primarily makes money by charging fees for diagnostic services delivered through its network of centres and collection points. Its revenue model is largely fee-for-service and is typically paid either out-of-pocket by...

Read more

Vijaya Diagnostic Centre Ltd. primarily makes money by charging fees for diagnostic services delivered through its network of centres and collection points. Its revenue model is largely fee-for-service and is typically paid either out-of-pocket by...

Vijaya Diagnostic Centre Ltd. Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	7.31B	6.81B	5.48B	4.59B	4.62B	3.76B
Gross Profit	5.88B	5.96B	4.82B	4.00B	3.91B	3.19B
EBITDA	3.12B	2.88B	2.38B	1.95B	2.15B	1.76B
Net Income	1.52B	1.43B	1.19B	846.32M	1.10B	844.78M
Balance Sheet
Total Assets	13.91B	12.74B	9.83B	8.53B	7.13B	5.41B
Cash, Cash Equivalents and Short-Term Investments	2.58B	2.33B	1.85B	2.55B	2.25B	2.20B
Total Debt	3.65B	3.20B	2.59B	2.48B	1.83B	1.41B
Total Liabilities	5.26B	4.74B	3.23B	3.07B	2.44B	1.82B
Stockholders Equity	8.65B	7.96B	6.57B	5.45B	4.68B	3.59B
Cash Flow
Free Cash Flow	453.03M	1.29B	953.37M	397.69M	356.50M	975.07M
Operating Cash Flow	1.39B	2.24B	1.83B	1.65B	1.58B	1.30B
Investing Cash Flow	-840.24M	-1.82B	-1.42B	-1.10B	-1.23B	-1.30B
Financing Cash Flow	-432.23M	-520.48M	-445.50M	-419.12M	-305.72M	-487.69M

Vijaya Diagnostic Centre Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1055.40
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VIJAYA, the sentiment is Positive. The current price of 1055.4 is above the 20-day moving average (MA) of 918.70, above the 50-day MA of 957.20, and above the 200-day MA of 1004.66, indicating a neutral trend. The MACD of -8.41 indicates Negative momentum. The RSI at 61.13 is Neutral, neither overbought nor oversold. The STOCH value of 92.06 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:VIJAYA.

Vijaya Diagnostic Centre Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VIJAYA	75 Outperform	₹100.16B	63.11	―	0.20%	16.71%	13.92%
HCG	67 Neutral	₹81.39B	-247.47	―	―	17.58%	-38.20%
METROPOLIS	61 Neutral	₹94.87B	60.35	―	0.21%	15.41%	5.93%
UNICHEMLAB	61 Neutral	₹23.58B	2.94	―	―	25.42%	―
KRSNAA	58 Neutral	₹19.29B	38.37	―	0.38%	11.51%	21.56%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Vijaya Diagnostic Centre Ltd. Corporate Events